Today: 26 January 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

AI Models Are Scheming – Inside OpenAI’s Plan to Stop Deceptive AI Behavior

OpenAI’s Mega AMD Deal: How a 6‑Gigawatt AI Chip Alliance Could Reshape the Arms Race

Background: Why OpenAI Needed More Silicon OpenAI’s mission to build artificial general intelligence (AGI) has become a capital‑intensive arms race. Training and running models like GPT‑5 or the video‑generating Sora require vast amounts of electricity and parallel compute. In March 2025, OpenAI’s CEO Sam Altman unveiled a plan for Stargate, a U.S.‑based supercomputer project initially expected to cost $100 billion and deliver one…
6 October 2025
····
Micron’s AI-Fueled Q4 2025 Earnings Shatter Expectations, Stock Soars to New Highs

Micron’s AI-Fueled Surge: Record Highs, Bold Forecasts, and What’s Next for MU in 2025

Stock Performance Soars in 2025 Micron’s stock has been on a tear in 2025, far outpacing the broader market. As of early October, MU shares have climbed over 90% year-to-date (including an eye-popping 40% surge in September alone) ts2.tech. The stock recently notched a fresh all-time high, touching $191.85 before pulling back slightly Marketbeat. By October 6, Micron was trading…
6 October 2025
··
IBM Stock Soars on Quantum Breakthrough and AI Revival – Key Updates (Sept 25, 2025)

IBM’s AI Revolution Sends Stock Soaring as Big Blue Takes on Tech Giants

Stock Performance: Riding High into October IBM’s stock has been on a steady upswing and enters October 2025 trading near its highest levels in years. The stock closed at $288.37 on Friday, Oct 3 Financialcontent, essentially flat to slightly up over the past few days. It’s hovering just shy of its 52-week peak (around $296) after a late-September jump. In fact,…
6 October 2025
···
UiPath’s AI Gold Rush: OpenAI, NVIDIA & Google Deals Ignite PATH’s Stock Rally

UiPath (PATH) Stock Soars on AI Deals and Strong Earnings – 2025 Update

UiPath Inc.’s emphasis on new AI partnerships and products has fueled a stock rally in late 2025. Financial Performance at a Glance (Q2 FY2026) To contextualize UiPath’s recent performance, below is a summary of key financial metrics for the quarter ended July 31, 2025 (Q2 FY2026), compared to the prior year’s quarter where available: Metric Q2 FY2026 (Jul 2025) YoY Change Revenue…
6 October 2025
···
NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia’s AI Juggernaut: What You Need to Know About NVDA After the $100 Billion OpenAI Deal and Its Record Rally (Oct 2025)

Recent News (Late Sept – Oct 6 2025) AMD–OpenAI Partnership Challenges Nvidia’s Dominance Reuters and technology outlets reported on Oct 6 that AMD signed a multi‑year deal to supply hundreds of thousands of AI GPUs (6 GW) to OpenAI. The deal gives OpenAI an option to buy up to 10 % of AMD. AMD expects tens of billions of dollars annually from the partnership and more than…
6 October 2025
····
White House’s Shocking 10% Intel Stake Plan Shakes the Tech World

Intel Corporation (INTC) – Oct 6 2025: A Tumultuous Rally, Government Stake and New Hope in AI Chips

Intel Corporation (INTC) has been one of 2025’s most talked‑about semiconductor stocks. After years of delays and sliding market share, the 2025 rally has been driven by a combination of massive government and corporate investments, rumours of new strategic customers, and hope that a leaner, AI‑focused Intel can eventually compete with rivals. INTC finished Oct 3 2025 at $36.73, near its 52‑week…
6 October 2025
···
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly Stock Rockets on GLP‑1 Boom and New Approvals: Is LLY the Next Trillion‑Dollar Pharma Titan?

In‑Depth Report Introduction Eli Lilly and Company (NYSE: LLY) has become the poster‑child for the emerging class of GLP‑1‑based obesity and diabetes therapies. Its injectable tirzepatide products Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management) have delivered explosive growth, propelling the company’s market capitalization into the high‑hundred‑billion range. On 6 Oct 2025, LLY traded around $840, close to its all‑time highs Marketbeat.…
6 October 2025
···
AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

Stock Performance & Market Valuation Advanced Micro Devices (AMD) has been one of 2025’s semiconductor standouts. The stock trades around $164–$165 per share as of October 6, reflecting a dramatic rise this year Reuters. At a ~$267 billion market capitalization Reuters, AMD is now the world’s third-most valuable chip maker – still a fraction of Nvidia’s size, but a testament to…
6 October 2025
···
Bitcoin ETF Frenzy: BlackRock’s IBIT Soars Past $90B as Uptober 2025 Rally Sets Records

Bitcoin ETF Frenzy: BlackRock’s IBIT Soars Past $90B as Uptober 2025 Rally Sets Records

Uptober 2025: Bitcoin’s Rally and IBIT’s Breakout Moment Early October 2025 brought a perfect storm of bullish catalysts for Bitcoin – and IBIT was a major beneficiary. After a sluggish summer, Bitcoin erupted in a classic “Uptober” surge, soaring past $120K and closing in on its all-time high ts2.tech. By October 3, BTC reached ~$123,300 intraday, less than 2% shy…
6 October 2025
····
Oracle’s ‘Truly Awesome’ AI Cloud Quarter Sends Stock Soaring 36%, Making Ellison World’s Richest

Oracle’s $300B AI Cloud Gamble – Can ORCL Stock Become the Next $1 Trillion Tech Titan?

Recent Stock Performance and Valuation Metrics Oracle’s stock has been on a tear in 2025, dramatically outpacing the broader market thanks to AI cloud enthusiasm. Shares started the year around the $170s and climbed into the high $200s by early October, after an especially explosive move in September. The catalyst was Oracle’s Fiscal Q1 2026 earnings release on Sept. 9,…
6 October 2025
····
Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Rigetti’s $13 Billion Quantum Leap – Stock Hits Record High on Big Deals, But Is the Hype Real?

Stock Performance: Skyrocketing to Record Highs Rigetti Computing’s stock (NASDAQ: RGTI) has been on a tear, soaring to record levels heading into October 2025. On October 6, shares opened around $40.06 – essentially at all-time highs Marketbeat. This price is astounding given RGTI traded below $1 at its low; in fact, the 52-week range spans $0.73 to $40.63 Marketbeat. The…
6 October 2025
···
Coinbase (COIN) Stock Crashes in Crypto Sell-Off – Can It Bounce Back?

Coinbase’s October 2025 Firestorm: price surges, trust charter bid & analysts call COIN the “most misunderstood” stock

Key facts (October 6 2025) Stock performance and technical outlook Price action through October 6 2025 At the close on October 3 2025, COIN shares ended at $380.02, with a trading range of $370.03–$383.50 and volume of 13.6 million shares Stockanalysis. This capped a strong week: the stock rose from $312.59 on September 26 (during a crypto sell‑off) to $380 amid a broader digital‑asset rally ts2.tech. Pre‑market data…
6 October 2025
····
1 … 409 410 411 412 413 … 584

Stock Market Today

  • Goldman Sachs Highlights 13 Value Stock Picks as ASX Value Rally Expands
    January 25, 2026, 9:18 PM EST. Value stocks on the Australian Securities Exchange (ASX) have surged, led by commodity stocks such as gold miners. Goldman Sachs reports its ASX value stock basket rose 49% since July, with a 21% jump in the December quarter and an additional 7% gain in early 2024. Matthew Ross, Goldman Sachs' local equity strategist, sees potential for this rally to widen beyond commodities. This reflects a broader comeback for value stocks after a prolonged period in the market wilderness. Investors are watching closely as these picks could shape the near-term performance of the ASX.
Go toTop